In what circumstances could nondaily preexposure prophylaxis for HIV substantially reduce program costs?

about

In what circumstances could nondaily preexposure prophylaxis for HIV substantially reduce program costs?

Item

http://www.wikidata.org/entity/Q50051642

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

In what circumstances could no ...... antially reduce program costs?

@en

In what circumstances could no ...... antially reduce program costs?

@nl

type

Item

label

In what circumstances could no ...... antially reduce program costs?

@en

In what circumstances could no ...... antially reduce program costs?

@nl

prefLabel

In what circumstances could no ...... antially reduce program costs?

@en

In what circumstances could no ...... antially reduce program costs?

@nl

P1476

In what circumstances could no ...... antially reduce program costs?

@en

P2093

Anupong Chitwarakorn

http://www.w3.org/2001/XMLSchema#string

Dobromir Dimitrov

http://www.w3.org/2001/XMLSchema#string

Fan Xia

http://www.w3.org/2001/XMLSchema#string

James P Hughes

http://www.w3.org/2001/XMLSchema#string

Kate M Mitchell

http://www.w3.org/2001/XMLSchema#string

Kevin Bokoch

http://www.w3.org/2001/XMLSchema#string

Robert M Grant

http://www.w3.org/2001/XMLSchema#string

Sharon Mannheimer

http://www.w3.org/2001/XMLSchema#string

Timothy H Holtz

http://www.w3.org/2001/XMLSchema#string

P2860

Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

Preexposure Prophylaxis For HIV Prevention: What We Know and What We Still Need to Know for Implementation

The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling study

The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies

Cost-effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV-1 infections in rural Zambia: a modeling study

Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trial

Effectiveness and cost effectiveness of oral pre-exposure prophylaxis in a portfolio of prevention programs for injection drug users in mixed HIV epidemics

Evaluating the cost-effectiveness of pre-exposure prophylaxis (PrEP) and its impact on HIV-1 transmission in South Africa

How can we get close to zero? The potential contribution of biomedical prevention and the investment framework towards an effective response to HIV.

P304

809-818

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0000000000001766

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29424774

http://www.w3.org/2001/XMLSchema#string

P932

5854532

http://www.w3.org/2001/XMLSchema#string